Results 241 to 250 of about 138,704 (292)

Histone deacetylase inhibitors in lymphoma

Current Opinion in Oncology, 2010
Although many advances have been made in the treatment of lymphoma in the past decade, the treatment of patients with relapsed and refractory disease remains challenging. Only a fraction of patients will be cured with salvage therapy and transplantation.
Amanda, Copeland, Daniela, Buglio, Anas, Younes   +2 more
openaire   +2 more sources

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

Nature Reviews. Cancer, 2006
S. Minucci, P. Pelicci
semanticscholar   +1 more source

Hydrazides as Inhibitors of Histone Deacetylases

Journal of Medicinal Chemistry
In this Perspective, we have brought together available biological evidence on hydrazides as histone deacetylase inhibitors (HDACis) and as a distinct type of Zn-binding group (ZBG) to be reviewed for the first time in the literature. N-Alkyl hydrazides have transformed the field, providing innovative and practical chemical tools for selective and ...
Maria do Carmo Carreiras, José Marco-Contelles   +1 more
openaire   +3 more sources

Histone Deacetylase Inhibitors

Resistance to Targeted Anti-Cancer Therapeutics, 2021
O. Sefhore, S. C. Ling
semanticscholar   +1 more source

Inhibitors of Histone-deacetylases

Tumori Journal, 2001
openaire   +3 more sources

Histone Deacetylase Inhibitors as a Novel Targeted Therapy Against Non-small Cell Lung Cancer: Where Are We Now and What Should We Expect?

Anticancer Research, 2018
C. Damaskos, I. Tomos, N. Garmpis, A. Karakatsani, D. Dimitroulis, A. Garmpi, E. Spartalis, C. Kampolis, Eleni Tsagkari, A. Loukeri, G. Margonis, M. Spartalis, N. Andreatos, Dimitrios Schizas, Stefania Kokkineli, E. Antoniou, A. Nonni, G. Tsourouflis, K. Markatos, K. Kontzoglou, A. Kostakis, P. Tomos   +21 more
semanticscholar   +1 more source

INHIBITORS OF HISTONE DEACETYLASE

2008
TESSIER PIERRE, LEIT SILVANA, SMIL DAVID, DEZIEL ROBERT, AJAMIAN ALAIN, CHANTIGNY YVES ANDRE, DOMINGUEZ CELIA   +6 more
  +19 more sources

Safety and Tolerability of Histone Deacetylase (HDAC) Inhibitors in Oncology

Drug Safety, 2019
R. Shah
semanticscholar   +1 more source

Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer.

Cancer Cell, 2016
Hanlin Zeng, J. Qu, N. Jin, Jun Xu, Chenchu Lin, Yi Chen, Xinying Yang, Xiangxi He, Shuai Tang, Xiaojing Lan, Xiaotong Yang, Ziqi Chen, Min Huang, Jian Ding, M. Geng   +14 more
semanticscholar   +1 more source

Histone deacetylase inhibitors: discovery and development as anticancer agents

Expert Opinion on Investigational Drugs, 2005
Miloš Dokmanović, Paul A Marks
exaly